Normalization of the ovarian cancer microenvironment by SPARC. Mol Cancer Res 2007 Oct;5(10):1015-30
Date
10/24/2007Pubmed ID
17951402DOI
10.1158/1541-7786.MCR-07-0001Scopus ID
2-s2.0-35948982192 (requires institutional sign-in at Scopus site) 82 CitationsAbstract
Malignant ascites is a major source of morbidity and mortality in ovarian cancer patients. It functions as a permissive reactive tumor-host microenvironment and provides sustenance for the floating tumor cells through a plethora of survival/metastasis-associated molecules. Using a syngeneic, immunocompetent model of peritoneal ovarian carcinomatosis in SP(-/-) mice, we investigated the molecular mechanisms implicated in the interplay between host secreted protein acidic and rich in cysteine (SPARC) and ascitic fluid prosurvival/prometastasis factors that result in the significantly augmented levels of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP). Ascitic fluid-enhanced ID8 invasiveness was mediated through VEGF via a positive feedback loop with MMP-2 and MMP-9 and through activation of alpha(v) and beta(1) integrins. Host SPARC down-regulated the VEGF-MMP axis at the transcriptional and posttranscriptional levels. In vitro, SPARC attenuated the basal as well as VEGF-induced integrin activation in tumor cells. SPARC inhibited the VEGF- and integrin-mediated ID8 proliferation in vitro and significantly suppressed their tumorigenicity in vivo. Relative to SP(+/+), SP(-/-) ascitic fluid contained significantly higher levels of bioactive lipids and exerted stronger chemotactic, proinvasive, and mitogenic effects on ID8 cells in vitro. SP(-/-) ascites also contained high levels of interleukin-6, macrophage chemoattractant protein-1, and 8-isoprostane (prostaglandin F(2)alpha) that were positively correlated with extensive infiltration of SP(-/-) ovarian tumors and ascites with macrophages. In summary, our findings strongly suggest that host SPARC normalizes the microenvironment of ovarian cancer malignant ascites through down-regulation of the VEGF-integrin-MMP axis, decreases the levels and activity of bioactive lipids, and ameliorates downstream inflammation.
Author List
Said N, Socha MJ, Olearczyk JJ, Elmarakby AA, Imig JD, Motamed KMESH terms used to index this publication - Major topics in bold
AnimalsAscitic Fluid
Carcinoma
Cell Adhesion
Cell Proliferation
Cell Survival
Chemokine CCL2
Dinoprost
Female
Inflammation
Integrins
Interleukin-6
Metalloendopeptidases
Mice
Mice, Mutant Strains
Osteonectin
Ovarian Neoplasms
Peritoneal Neoplasms
Tissue Inhibitor of Metalloproteinases
Vascular Endothelial Growth Factor A